Samsung Biologics is a corporate investor based in Incheon, South Korea, founded in 2011. Verified contact details, AUM data, and investment preferences on FindLPs.
Samsung Biologics is a corporate investor based in Incheon, South Korea. Founded in 2011. Reported AUM: $9.1B.
Investment types: Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General)
Sectors & themes: Biotechnology, Healthcare, Pharmaceuticals
Preferred geographies: Asia, East and Southeast Asia, Emerging Markets, North America, OECD
Location: 300, Songdo bio-daero Yeonsu-gu
FindLPs holds verified direct email addresses and phone numbers for decision-makers at Samsung Biologics. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.
Unlock Contact DetailsSearch 25,850 limited partners with verified contact details.
LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.